Getty / Justin Sullivan
Google's goal is "an early heads-up" on disease to ultimately facilitate more effective treatment.
Google's particles will be less than 1/000 the width of a red blood cell and would attach themselves to specific cells, proteins, and other molecules inside the body. For example, Google could coat its nanoparticles with an antibody that would recognize and attach to a protein on the surface of a tumor cell.
Google is also working on a wearable device that would attract and count the particles. In that way, the system would be used for testing and monitoring health: You could be alerted through the wearable if a lot of the particles were attaching to tumor cells. Google admits, however, that it still needs to better understand what constitutes as a healthy level of disease-carrying molecules in the blood and what would be a cause for a concern.
Google would likely let people consume its nanoparticles through a pill, but is reportedly at least five to seven years away from a product that would be approved by doctors.
"Every test you ever go to the doctor for will be done through this system," Andrew Conrad, head of the Life Sciences team at Google X, said at The Wall Street Journal's "WSJD Live" conference. "That's our dream."